Please login to the form below

Not currently logged in
Email:
Password:

Diabetes UK

This page shows the latest Diabetes UK news and features for those working in and with pharma, biotech and healthcare.

Merck to pilot digital behavioural change programme

Merck to pilot digital behavioural change programme

Merck last year received UK approval for its mature oral diabetes drug Glucophage (metformin) to treat non-diabetic hyperglycaemia or pre-diabetes and is looking to add ‘beyond the pill’services ... Meanwhile, Roche acquired smartphone-based diabetes

Latest news

  • Roche offers diabetes digital health programme to UK patients Roche offers diabetes digital health programme to UK patients

    Roche offers diabetes digital health programme to UK patients. Partners with OurPath for its six-week lifestyle management programme. ... Roche has beefed up its diabetes digital health services, launching a lifestyle management programme for patients in

  • MHRA joins Instagram as part of Yellow Card drive MHRA joins Instagram as part of Yellow Card drive

    MHRA joins Instagram as part of Yellow Card drive. UK medicines regulator follows in the footsteps of NICE in using the channel. ... month. NICE has focused on AMR and diabetes to date, while the UK medicines regulator has so far been using Instgram to

  • Sanofi’s diabetes IMPACT programme wins at PMEA 2017 Sanofi’s diabetes IMPACT programme wins at PMEA 2017

    Sanofi’ s diabetes IMPACT programme wins at PMEA 2017. Takes home first place in Excellence in Demonstrating Economic and Societal Value. ... The programme - which Sanofi worked on in collaboration with Diabetes UK and JDRF, a type 1 diabetes charity -

  • Novo Nordisk invests £115m in Oxford diabetes unit Novo Nordisk invests £115m in Oxford diabetes unit

    Novo Nordisk invests £115m in Oxford diabetes unit. But Danish pharma company admitted Brexit had made it a harder decision. ... on the discovery and development of new drugs for type 2 diabetes and complications such as kidney and nerve damage.

  • Sanofi launches ‘Highs & Lows’ diabetes awareness campaign Sanofi launches ‘Highs & Lows’ diabetes awareness campaign

    Dr Mike Baxter, medical therapy expert at Sanofi UK, said: “ Our research shows that there is a need in the UK for better support for people with type 2 diabetes - not ... Consequently, the level of diabetic control in a large number of people with

More from news
Approximately 6 fully matching, plus 126 partially matching documents found.

Latest Intelligence

  • Positive disruption in business intelligence Positive disruption in business intelligence

    In an analysis of 47, 000 UK HCP posts about type 2 diabetes, 58% of mentions of named drugs were about drug trial data. ... Take the recent recommendation by NICE, the UK’s drug-spending policymaker, of Kadcyla, the breast cancer treatment launched by

  • Transforming B2B healthcare marketing Transforming B2B healthcare marketing

    Instead, the shoes represented the number of people who lose a limb to diabetes each week. ... Of course, the shop also had the ‘what’and the ‘how’covered too, with Diabetes UK staff on-site to dispense information and the ‘Know Your

  • The future of communications is closer than you think The future of communications is closer than you think

    Physician predictions: patient interaction. We talked to Dr Partha Kar, a Diabetes Consultant in the UK, to understand how technology is helping to support better doctor-patient interactions today and what ... You have diabetes. You are the expert. I am

  • It's time to get diabetes right It's time to get diabetes right

    iii. Diabetes UK, web page: 'Report shows that 24, 000 people in England suffer avoidable death' (2011). ... iv. N. Hex et al., Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect

  • Designing unique patient solutions in rare disease Designing unique patient solutions in rare disease

    She has collaborated with Diabetes UK, Women’ s Health Concern, the Cure Parkinson’ s Trust, National Rheumatic Arthritis Care society and many more patient advocacy groups in the United Kingdom.

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Ashfield, Health Unlimited and Ashley Communications adds to their teams Ashfield, Health Unlimited and Ashley Communications adds to their teams

    Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK diabetes team. ... Pierre’s insight and knowledge of our market place will be invaluable as

  • Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare

    Kirby sent seven years at the pharma firm, most recently serving as regional business manager in the UK for its diabetes sales team across the south east.

  • Hayward Medical Communications adds to its team Hayward Medical Communications adds to its team

    Hayward Medical Communications adds to its team. Paul Thomas and Alice Pinion among the UK agency's new recruits. ... Prior to that his roles included working as an NHS commercial director and a spell as head of sales, north UK in diabetes for Novo

  • Portland Health adds to staff as business grows Portland Health adds to staff as business grows

    Portland Health adds to staff as business grows. Follows a number of new business wins for the UK agency. ... With experience in a wide range of therapeutic areas, she has advised the likes of Abbott UK, MSD, Novartis Oncology UK, Pfizer UK, Sanofi

  • Silence appoints chief medical officer Silence appoints chief medical officer

    Dr Khan's work has covered cancer and diabetes, and he has written several books on the subjects. ... In addition, Dr Khan is a fellow of the Royal College of Physicians of London and a member of the Association of Physicians, HEART-UK and Diabetes UK.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Getting personal with wearable tech

    In partnership with Diabetes UK and Hewlett Packard it is deploying mobile health self-management tools (wearable sensors and software) for people with Type 1 and Type 2 diabetes to ... We’ ll leave this thought with you…. Kris Barker, Associate

  • Leading NHS suppliers highlighted in shortlist for new HSJ awards

    Facilities management supplier. London Ambulance Service Trust/Interserve. Compass Group UK&I Healthcare. ... Novartis Oncology. Novartis Oncology Market Access. Novo Nordisk and Diabetes UK.

  • B2B healthcare marketing is in need of a transformation

    Instead, the shoes represented the number of people losing a limb to diabetes each week. ... Of course, the shop also had the “ what” and the “ how” covered too, with Diabetes UK staff on-site to dispense information and the ‘ Know Your Risk’

  • Say Communications

    Rare Disease UK. Roche Diabetes Care. Roche Diagnostics. SOBI. Versapak. ... Digital health specialists Aegleio suggest that a culture change is needed to cope with the rise of diabetes in the UK.

  • Four Health Communications

    Clients. Actelion (global and UK); pulmonary arterial hypertension, Niemann-Pick type C disease. ... Gilead (global and UK); HIV, Hepatitis C,. NovoNordisk; diabetes. Galen; pain relief.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics